Clinical Trial Update: A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating the combination of picoplatin and docetaxel in men with hormone-refractory prostate cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Picoplatin (picoplatin)

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Hormone Refractory Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN